House Democrats launch inquiry into Medicare stimulus payouts

Published 05/29/2020, 03:40 PM
Updated 05/29/2020, 09:01 PM
© Reuters. Rep. Porter participates in a House Financial Services Committee hearing with Facebook Chairman and CEO Mark Zuckerberg in Washington

By Sarah N. Lynch and Marisa Taylor

WASHINGTON (Reuters) - Two U.S. House of Representatives Democrats on Friday launched an inquiry into whether the Health and Human Services Department misdirected billions of dollars in coronavirus stimulus money to healthcare providers facing criminal or civil fraud investigations.

In a letter to Secretary Alexander Azar, Representatives Lloyd Doggett and Katie Porter accused the department of evading questions about how it decided to dole out $50 billion for its provider relief fund and demanded answers about how the funds will be clawed back from possible fraudsters.

Reuters reported exclusively this month that HHS had sent Medicare providers under criminal and civil investigations stimulus money, after it direct-deposited $30 billion into the bank accounts of any medical provider who billed Medicare for services in 2019.

Doggett and Porter cited Reuters' reporting in their letter.

"Funds meant for frontliners went to hospitals previously closed, mega-corporations, and possible fraudsters," Doggett said in a statement. "The Trump Administration should immediately provide a full accounting of how these millions landed, as they so often do with this Administration, in the pockets of corporate interests and those under investigation for fraud."

An HHS spokesperson did not immediately respond to a request for comment on the letter.

Reuters could not determine what portion of the recipients are facing such inquiries.

After sending the funds, HHS asked all the providers to sign a lengthy attestation that stipulates they have been or will be treating patients suffering from COVID-19, the disease caused by the new coronavirus.

Those who do not respond by HHS' deadline will be assumed to have accepted the terms and conditions.

© Reuters. doggett_porter

HHS previously told Reuters it has mechanisms in place to recoup the funds and address fraud.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.